PTIX - Protagenic Therapeutics Inc
Previous close
0.5823
0 0%
Share volume: 1,378
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.58
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-6.68%
1 Month
-13.40%
3 Months
-57.01%
6 Months
-37.44%
1 Year
-68.09%
2 Year
-80.32%
Key data
Stock price
$0.58
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.50 - $1.98
52 WEEK CHANGE
-$0.67
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: protagenic.com
Employees: 1
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: protagenic.com
Employees: 1
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
protagenic therapeutics is a biotechnology company located in 1625th ave, new york, new york, united states.
Recent news